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Matrix-assisted laser desorption ionization time-of-flight mass spectrometry (MALDI-TOFMS)
is used to obtain fast and accurate determinations of molecular mass, but quantitative
determinations are generally made by other techniques. In this study we illustrate the practical
utility of automated MALDI-TOFMS as a tool for quantifying a diverse array of biomolecules
covering an extensive molecular weight range, and present in biological extracts and fluids.
Growth hormone was measured in rat pituitary tissue; insulin in human pancreatic tissue;
homovanillic acid in human urine; and LVV-hemorphin-7, epinephrine and norepinephrine in
human adrenal and pheochromocytoma tissues. Internal standards including compounds of
similar molecular weight, structural analogs or isotopomers were incorporated into each
analysis. We report on the current practical limitations of quantitative MALDI-TOFMS and
highlight some of the potential benefits of this technique as a quantitative tool. (J Am Soc
Mass Spectrom 2002, 13, 1015–1027) © 2002 American Society for Mass Spectrometry
Since its inception and commercial availability, theversatility of MALDI-TOFMS has been demon-strated convincingly by its extensive use for qual-
itative analysis. For example, MALDI-TOFMS has been
employed for the characterization of synthetic polymers
[1, 2], peptide and protein analysis [3–5], DNA and
oligonucleotide sequencing [6–8], and the characteriza-
tion of recombinant proteins [9, 10]. Recently, applica-
tions of MALDI-TOFMS have been extended to include
the direct analysis of biological tissues and single cell
organisms with the aim of characterizing endogenous
peptide and protein constituents [11–18].
The properties that make MALDI-TOFMS a popular
qualitative tool—its ability to analyze molecules across
an extensive mass range, high sensitivity, minimal
sample preparation and rapid analysis times—also
make it a potentially useful quantitative tool. MALDI-
TOFMS also enables non-volatile and thermally labile
molecules to be analyzed with relative ease. It is there-
fore prudent to explore the potential of MALDI-TOFMS
for quantitative analysis in clinical settings, for toxico-
logical screenings, as well as for environmental analy-
sis. In addition, the application of MALDI-TOFMS to
the quantification of peptides and proteins is particu-
larly relevant. The ability to quantify intact proteins in
biological tissue and fluids presents a particular chal-
lenge in the expanding area of proteomics and investi-
gators urgently require methods to accurately measure
the absolute quantity of proteins.
While there have been reports of quantitative
MALDI-TOFMS applications, there are many problems
inherent to the MALDI ionization process that have
restricted its widespread use [19–39]. These limitations
primarily stem from factors such as the sample/matrix
heterogeneity that is believed to contribute to the large
variability in observed signal intensities for analytes,
the limited dynamic range due to detector saturation,
and difficulties associated with coupling MALDI-
TOFMS to on-line separation techniques such as liquid
chromatography. Combined, these factors are thought
to compromise the accuracy, precision, and utility with
which quantitative determinations can be made.
Because of these difficulties, practical examples of
quantitative applications of MALDI-TOFMS have been
limited. Most of the studies to date have focused on the
quantification of low mass analytes, in particular, alka-
loids or active ingredients in agricultural or food prod-
ucts [40–45], whereas other studies have demonstrated
the potential of MALDI-TOFMS for the quantification
of biologically relevant analytes such as neuropeptides,
proteins, antibiotics, or various metabolites in biological
tissue or fluid [23, 27–29, 33, 35, 38, 46].
In earlier work we were able to show that linear
calibration curves could be generated by MALDI-
TOFMS provided that an appropriate internal standard
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was employed [33]. This standard can “correct” for both
sample-to-sample and shot-to-shot variability. Never-
theless, our work was restricted to low mass analytes:
The catecholamines, acetylcholine, and a peptide. We
were severely hampered by the limited mass resolution
of our previous instrument (Finnigan Lasermat 2000),
so it was only in those few instances where we could
completely resolve the analyte and internal standard
that satisfactory quantification was achievable. Stable
isotope labeled internal standards (isotopomers) gave
the best result; when we employed a structural analog
as the internal standard it was at the expense of both
accuracy and precision.
With the marked improvement in resolution avail-
able on modern commercial instruments, primarily
because of delayed extraction [47, 48], the opportunity
to extend quantitative work to other examples is now
possible; not only of low mass analytes, but also
biopolymers. Of particular interest to us is the prospect
of absolute multi-component quantification in biologi-
cal samples (e.g., proteomics applications).
This study explores the utility of MALDI-TOFMS for
the quantification of five different biomolecules in bio-
logical tissue or fluid: homovanillic acid in human
urine; catecholamines (epinephrine and norepineph-
rine) in human adrenal tissue; insulin in human pan-
creatic tissue; LVV-hemorphin-7 in human adrenal
gland; and growth hormone in the rat pituitary gland.
These samples cover a wide mass range and represent
practical examples of quantification in complex real-
world biological matrices.
Methods
Materials and Reagents
Trifluoroacetic acid (TFA), norepinephrine hydrochlo-
ride, homovanillic acid (HVA), -lactoglobulin, 4-hy-
droxy-3-methoxycinnamic acid (ferulic acid), porcine
insulin, and bovine serum albumin (BSA) were all
obtained from Sigma Chemical Co. (Sydney, NSW, Aus-
tralia). Recombinant methionyl rat growth hormone (met-
rGH, 97% monomer; 21,943 Da) was purchased from
Gropep Pty. Ltd. (Adelaide, SA, Australia). Epinephrine,
-cyano-4-hydroxycinnamic acid (4HCCA), 2,5-dihy-
droxybenzoic acid (DHB), and 3,5-dimethoxy-4-hydroxy-
cinnamic acid (sinapinic acid) were obtained from Aldrich
Chemical Co., Inc. (Milwaukee, WI). Caffeic acid was
purchased from ICN Biomedical Inc. (Aurora, OH). Syn-
thetic rat LVV-hemorphin-7 (H–LVVYPQWTQRY–OH)
and synthetic human LVV-hemorphin-7 (H–LVVYP-
WTQRF–OH) were custom synthesized by Chiron Tech-
nologies Pty., Ltd. (Clayton, Victoria, Australia). DL-
Norepinephrine--[2H3]HCl and 4-hydroxy-3-
methoxyphenyl-2,5,6-[2H3]-acetic-2,2-[
2H2] acid ([
2H5]-
HVA) were obtained from Merck and Co., Inc.,
(Rahway, NJ). DL-Epinephrine--[2H3] was a gener-
ous gift from Cambridge Isotope Laboratories (An-
dover, MA). Crystalline human insulin monocompo-
nent (CSL, Melbourne, Australia) was a gift from Assoc.
Professor B. E. Tuch, Prince of Wales Hospital, Sydney,
Australia. All other solvents and reagents were of the
highest grade available, and were obtained from com-
mercial suppliers. Water was purified by a Millipore
water purification system and had a resistivity 18
M/cm.
Sep-Pak C18 Cartridges (Waters Corporation, Mil-
ford, MA) were preconditioned with CH3CN:H2O:TFA
(80:20:0.1; 5 mL), and washed with dilute aqueous TFA
(0.1%; 10 mL) prior to use.
Sample Preparation
MALDI matrices and sample plate preparation. Sinapinic
acid (5 mg/mL), 4HCCA (5 mg/mL), and caffeic acid
(10 mg/mL) were prepared in CH3CN:H2O:TFA (80:20:
0.1). Ferulic acid (5 mg/mL) and DHB (10 mg/mL)
were prepared in 100% CH3CN.
All of the samples analyzed in this study were mixed
with the MALDI matrix solution immediately prior to
analysis. For those samples stored frozen, fresh dilu-
tions were made immediately before analysis. Aliquots
(0.5–1 L) were applied to between 10 and 20 sample
positions on a 100 position flat MALDI target (Persep-
tive Biosystems, Framingham, MA). Samples were
dried at room temperature and pressure. The number of
target positions used for each sample was chosen to
provide a suitable compromise between precision and
analytical speed.
Preparation of tissue extracts. Tissue slices (ca. 5–10 mg)
were shaved from frozen sections and accurately
weighed. The samples were macerated mechanically in
aqueous TFA (0.1%; 10 mg/mL) and an ultrasonic
probe was then employed to completely disrupt the
residual tissue. Internal standards were added and the
sample mixed thoroughly. Samples were then centri-
fuged (14,000 g, 15 min) and the supernatant collected
and stored.
ANALYSIS OF GROWTH HORMONE IN RAT PITUITARY
TISSUE. Male Sprague-Dawley rats 300 g body
weight) were decapitated and their pituitary glands (ca.
15–20 mg) were surgically removed and stored at 20
°C until required. Whole glands were extracted in
aqueous TFA (0.1%; 1.5 mL), and the internal standard
-lactoglobulin (15 nmol) was then added. Standard
solutions containing met-rGH (0, 10, 20, 40, 100, 150,
and 200 pmol) and -lactoglobulin (100 pmol) were
prepared in aqueous TFA (0.1%; 20 L) to generate the
standard curve. Standard solutions and samples were
then diluted 1:5 in caffeic acid solution before analysis.
Met-rGH was used in place of human growth hormone
(hGH) in the standards because it was readily accessi-
ble. We assumed that equal amounts of rat growth
hormone (rGH) and N-terminal methionyl rat growth
hormone (met-rGH) on target yield the same ion cur-
rent.
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ANALYSIS OF INSULIN IN HUMAN PANCREATIC TISSUE.
Control human pancreatic tissue was obtained from
cadavers (n  2) and frozen at 20 °C until analysis.
[Pancreas 1 was obtained from a 40 year old male road
traffic accident victim and pancreas 2 was from a 60
year old female who had suffered a subarachnoid
hemorrhage.] These tissues (3  ca. 50 mg lots of each)
were solubilized in dilute aqueous TFA (0.1%; 1 mL)
with the addition of porcine insulin (2.5 nmol) as the
internal standard. The extracts were passed through
preconditioned C18 Sep-Pak cartridges, washed with
aqueous TFA (0.1%; 5 mL), and the insulin was eluted
in CH3CN:H2O:TFA (80:20:0.1; 1 mL). Eluents were
evaporated under reduced pressure to yield aliquots of
ca. 50 L. These were mixed and diluted 1:20 in
sinapinic acid matrix solution and 1 L aliquots applied
to the MALDI target. Standard solutions containing
human insulin (0, 40, 120, 400, 1200, 2800, 4000 pmol)
and porcine insulin (200 pmol) were prepared in aque-
ous TFA (0.1%; 20 L; containing 5 nmol/mL BSA).
ANALYSIS OF HEMORPHINS AND CATECHOLAMINES IN
HUMAN ADRENAL AND PHEOCHROMOCYTOMA TISSUE.
Hemorphins. Extracts of control adrenal glands (n 10)
and surgically removed, histologically verified pheo-
chromocytoma (n 3) had previously been prepared as
described above, but with the addition of protease
inhibitors. Hemorphin content was determined by elec-
trospray MS at that time [49]. The extracts were then
stored at 20 °C until the present study. These same
extracts were thawed, mixed with rat LVV-hemor-
phin-7 (300 pmol/mg tissue, internal standard), diluted
1:30 with 4HCCA solution and then analyzed by
MALDI-TOFMS.
A single tissue extract, previously found to have the
lowest LVV-hemorphin-7 concentration, was employed
as the sample matrix for the preparation of a standard
addition calibration curve. Aliquots of this sample were
spiked with human LVV-hemorphin-7 (0, 10, 30, 60,
100, 300, and 600 pmol/mg tissue) and a fixed amount
of rat LVV-hemorphin-7 (300 pmol/mg tissue).
Control samples (n  3) were also included in the
analysis. These were prepared from each of the pheo-
chromocytoma extracts by adding internal standard
and spiking with human LVV-hemorphin-7 (100
pmol/mg tissue).
Catecholamines. Frozen tissue samples (70 °C; ca.
100 mg each) from control adrenal glands (n  3) and
histologically verified pheochromocytoma (n  3) were
extracted into aqueous TFA (0.1%, 1 mL) as previously
described.
Aliquots (10 L) from each tissue extract were mixed
with the internal standards (i.e., [2H3]-epinephrine {2
nmol} and [2H3]-norepinephrine {3 nmol}). The samples
were then diluted 1:25 in ferulic acid matrix solution,
mixed, cooled to 4 °C for 10 min and centrifuged (14,000
g, 10 min.) to precipitate protein. Aliquots (0.25 L) of
the supernatant were loaded directly on the MALDI
target for analysis.
An extract of surgically resected adrenal cortex was
employed as the sample matrix for the preparation of a
standard addition calibration curve. Aliquots of this
sample, each corresponding to 5 mg of tissue, were
spiked with 0, 0.5, 1.5, 3, 5, 15, 30, 45, 60, and 90 nmol of
both epinephrine and norepinephrine, together with
fixed amounts of the internal standards ([2H3]-epineph-
rine {20 nmol} and [2H3]-norepinephrine {30 nmol}).
These spiked extracts were diluted 1:25 in ferulic acid
solution prior to analysis.
ANALYSIS OF HOMOVANILLIC ACID IN HUMAN URINE
SAMPLES. Urine samples were collected from 19
healthy volunteers and adjusted to pH 2.5. The internal
standard, [2H5]-HVA (100 nmol) was added to aliquots
of each sample (50 L) and the mixture was extracted
into ethyl acetate (four volumes, three times). Extracts
were combined, taken to dryness under reduced pres-
sure and the residue reconstituted in dilute HCl (0.1 M,
50 L). Samples were diluted 1:10 in DHB matrix
solution and were then spotted on to the MALDI target.
Each urine sample was also independently analyzed for
HVA content at a commercial clinical chemistry labora-
tory.
Standard solutions containing HVA (0, 25, 50, 100,
500, and 1000 pmol) and [2H5]-HVA (100 pmol) were
prepared in water and diluted 1:5 in DHB matrix
solution prior to analysis (final volume 20 L).
Mass Spectrometry
Equipment. A Perseptive Voyager DE STR MALDI
time-of-flight mass spectrometer (Perseptive Biosys-
tems, Framingham, MA), equipped with a Tektronix
TDS 540C digital oscilloscope (500 MHz, digitization
rate 2 Gigasamples/s) was used for all mass spectro-
metry. The instrument was used in both positive ion
linear (LDE) and reflector (RDE) modes with delayed
extraction.
Data acquisition parameters. Samples were run in the
autosampler mode and the laser was operated at a fixed
fluence that was manually optimized for each sample
set. Optimization involved obtaining peaks with the
highest possible signal to noise ratio without significant
peak broadening. Laser firing patterns started at the
center of each sample spot and spiraled progressively
outwards to a notional spot perimeter. The laser fired
between 1 and 16 times at each location in the firing
pattern. For each sample spot, spectra meeting accep-
tance criteria (i.e., minimum and maximum peak inten-
sity thresholds) obtained from 256 laser shots were
averaged to form a single spectrum. The parameters
used for the analysis of each sample are summarized in
Table 1. Between 10 and 20 sample spots were analyzed
for each standard solution and biological sample.
For the hemorphin assay, the instrument was pro-
grammed to fire multiple laser shots at a single point on
the sample spot, averaging the intensity of the compos-
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ite spectrum in the digitizer, before downloading it to the
computer. The computer compared the spectrum with
user-defined minimum and maximum absolute intensity
criteria, and then either accepted or rejected each spec-
trum. If the full range of signal intensities is acquired,
individual spectra with high ion intensities for either the
analyte or internal standard can dominate averaged peak
ratio statistics in the final spectrum. To minimize this
problem, the hemorphin data were acquired using a small
number of laser shots per position (eight shots) with the
maximum intensity set to approximately one quarter of
the saturation limit. This approach reduced the available
instrument dynamic range, but kept analysis times rea-
sonably short (3 to 6 min per sample spot). Because we
were only interested in calibration over a dynamic range
of two orders of magnitude, this approach did not com-
promise the study.
An alternative approach, used for the HVA assay,
excludes saturated data from the final spectrum and
allows the instrument’s full dynamic range to be uti-
lized. Data from individual laser shots are downloaded
from the digitizer and signal intensity compared with a
user-defined maximum intensity threshold set just be-
low the saturation limit. This approach completely
eliminates saturated data without compromising the
dynamic range.
Mass calibration
GROWTH HORMONE. Spectra were externally mass
calibrated on the singly and doubly charged molecular
species of -lactoglobulin ([M  H]  18,364.4 Da and
[M  2H]2  9182.7 Da).
INSULIN. Insulin spectra acquired in LDE mode
were externally calibrated on the (average) mass of the
singly protonated molecule of porcine insulin ([M 
H]  5778.7 Da). Each spectrum acquired in RDE
mode was internally calibrated to correctly identify the
monoisotopic species in each insulin peak cluster. Each
mass spectrum was heavily smoothed (Savitsky-Golay,
second order polynomial, 150 points) to produce a
single peak for porcine insulin. The centroid of this
peak ([M  H]  5778.7 Da) was used to calibrate the
original isotopically resolved data.
HEMORPHINS. The mass spectrometer was exter-
nally calibrated using the monoisotopic protonated
molecular ion of substance P ([M  H]  1347.7 Da).
All data were acquired in LDE mode.
CATECHOLAMINES AND HOMOVANILLIC ACID. Cat-
echolamine and HVA data were acquired in RDE mode
at reduced accelerating voltage (7 kV). For the cat-
echolamines, each spectrum was internally calibrated
on the protonated molecules of [2H3]-epinephrine
([MH]  187.1162) and [2H3]-norepinephrine ([M
H]  173.1005). For homovanillic acid, spectra were
internally mass calibrated on the molecular ion of
[2H5]-HVA (M
  187.0893 Da) and the singly proton-
ated molecule of DHB (M  154.0266 Da).
Data processing and calibration curves. Individual spec-
tra were obtained for the analysis of each sample spot
and the heights of the relevant peaks were determined.
The analyte to internal standard peak height ratio was
calculated for each spectrum and then the mean value
and standard deviation were determined for each sam-
ple and standard. For homovanillic acid, peak area
ratios of analyte/internal standard were also deter-
mined to construct a calibration curve and to determine
its concentration in urine.
Calibration curves were constructed by plotting
mean values for the observed signal intensity ratio
against the nominal molar ratio. The calibration curves
were used to determine the concentration of each ana-
lyte in its respective biological matrix.
The RDE data obtained for insulin were processed in a
specific manner. The peak heights of the first eight iso-
topes of human insulin (5804.7 to 5811.7 Da) were re-
corded and summed. Similarly, the peak heights of the
corresponding ions (5774.7 to 5781.7 Da) in the porcine
insulin isotope cluster were recorded and summed. The
calibration curve was obtained by plotting the ratio of
summed analyte peak heights to summed internal stan-
dard peak heights against their nominal molar ratio.
Results and Discussion
Analysis of Growth Hormone in Rat Pituitary
Tissue
Growth hormone in rat pituitary tissue (n  2) was
successfully quantified using -lactoglobulin as the
internal standard. Figure 1 shows a MALDI mass spec-
trum of rat pituitary extract spiked with -lactoglobulin
Table 1. Acceptance criteria used for each sample
LDE
growth
hormone
LDE insulin
standard
curve
LDE
pancreatic
extracts
(insulin)
RDE insulin
standard
curve
RDE
pancreatic
extracts
(insulin)
LDE
hemorphins
RDE
catecholamine
RDE
homovanillic
acid
Minimum intensity 3,500 0 4,000 0 6,000 1,500 1,500 5,000
Maximum intensity 62,000 63,000 20,000 63,000 63,000 15,000 15,000 63,000
Positions in search pattern 500 500 203 500 203 26 81 500
Laser shots per position 1 1 16 1 12 8 12 1
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(15 nmol; ([M  H]  18,364.4 Da) with caffeic acid as
the matrix and run in LDE mode. The amount of
internal standard applied to the target was 5 pmoles.
The peak height ratio was calculated, and then con-
verted to a molar ratio by reference to the calibration
curve. At higher mass, the doubly charged species for
these proteins, as well as other minor protein compo-
nents from the pituitary gland. Figure 2 shows the
calibration curve obtained for rat methionyl growth
hormone ([M  H]  21,812.1 Da) without correction
based on the internal standard (-lactoglobulin). The
curve was constructed by plotting the average signal
intensity for 10 determinations (y-axis) against the
amount of methionyl growth hormone applied to the
MALDI target (x-axis). Figure 3 shows the calibration
curve obtained for rat methionyl growth hormone cor-
rected with -lactoglobulin, the internal standard. In
this case, peak height ratios of analyte to internal
standard were used to construct the calibration curve.
Plotting the ratio of analyte/internal standard mark-
edly increased the precision, but it is important to note
that the internal standard has no sequence homology
Figure 1. A representative MALDI mass spectrum for growth hormone ([M  H] 21,808 Da) in a
rat pituitary extract. -Lactoglobulin (15 nmol, [M  H] 18,364 Da) was added as an internal
standard and caffeic acid was used as the MALDI matrix.
Figure 2. A representative standard curve obtained for methio-
nyl rat growth hormone (met-rGH, 0–200 pmol) without an
internal standard. The plot is the average peak height ratios for
met-rGH (y-axis) plotted against amount (x-axis) applied to the
MALDI target. Error bars represent standard deviations.
Figure 3. A representative standard curve obtained for methio-
nyl rat growth hormone (met-rGH, 0–200 pmol) using -lacto-
globulin (100 pmol) as the internal standard. The plot is the
average peak height ratios for met-rGH to -lactoglobulin (n 10)
plotted against molar concentration ratio. Error bars represent
standard deviation.
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with the analyte in this specific example. This is less
than ideal, but a comparision of Figures 2 and 3
indicates that the internal standard still serves a useful
function and enhances precision. The corrected calibra-
tion curve is linear (R2  0.997, slope  1.17) over the
relative analyte/internal standard concentration range
0.1 to 2.0 (1–21 mol/g tissue or 0–200 pmol met-GH),
but has a non-zero intercept. The deviation of the data
from the line of best fit at higher molar ratios is likely a
consequence of the compromise with internal standard
selection. (See the results for the quantification of insu-
lin that follow.)
The concentrations of rGH in 2 rat pituitary glands
were determined (2.40  0.23 and 2.49  0.25 mol/g
tissue; mean  SD). These values fall within the pub-
lished concentration range for rGH in rat pituitary
gland [50]. Coefficients of variation for rGH determina-
tions in rat pituitary extracts were below 20% (n  10).
Analysis of Insulin in Human Pancreatic Tissue
Spectra showing baseline resolved (single) peaks for
human ([M  H]  5808.7 Da) and porcine insulin
([M  H]  5778.7 Da) were obtained in LDE mode.
Spectra obtained in RDE mode showed isotopically
resolved peak clusters for each peptide. (Figure 4 shows
the sequences for both human and porcine insulins;
Figures 5a and b the spectra obtained in LDE and RDE
mode). Calibration curves were obtained for insulin in
both LDE (R2  0.999, slope 1.08) and RDE (R2 
0.999, slope  0.98) modes (Figure 6) over the analyte/
internal standard relative concentration range 0.06 to
3.0 (equivalent to 3–150 nmol/g tissue). The results
from analysis of multiple sections of two pancreatic
tissues are shown in Table 2. Insulin concentrations
measured in the two modes were comparable; however,
coefficients of variation for the LDE determinations
were considerably better than those generated in RDE
mode, consistent with the significantly higher absolute
peak intensity and signal-to-noise ratio observed in the
LDE spectra.
Quantification of Hemorphins in Human Adrenal
and Pheochromocytoma Tissue
Spectra showing isotopically resolved peaks for human
LVV-hemorphin-7 (monoisotopic [M  H]  1308.7
Da) and rat LVV-hemorphin-7 (monoisotopic [M 
H]  1324.7 Da) were obtained. A standard addition
curve in an adrenal extract was constructed and was
linear (R2  0.999) over the analyte added/internal
standard relative concentration range 0.03 to 2.0 (7 to
500 nmol/g tissue). Control samples were prepared
from the pheochromocytoma samples by spiking them
Figure 4. The amino acid sequence for human and porcine insulin. Insulin is composed of two
subunits joined by two intramolecular disulfide bonds. Insulin A chain consists of 21 amino acids and
insulin B chain consists of 30 amino acids. Shown are the amino acid sequences for porcine and human
insulin A and B chains. The sequences for these polypeptides differ by one amino acid (highlighted).
Figure 5. Mass spectra showing human insulin (400 pmol) and
porcine insulin (internal standard, 200 pmol) acquired in (a) LDE
mode and (b) RDE mode.
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with human LVV-hemorphin-7 (100 nmol/g tissue).
The control samples yielded values that were 124  14,
112  16, and 100  6 nmol/g higher than the corre-
sponding pheochromocytoma samples, consistent with
the amount spiked into each.
The results obtained for the MALDI analysis of 10
adrenal tissues and 3 pheochromocytoma samples are
compared with results obtained from a previous elec-
trospray MS analysis of the same extracts in Figure 7
[49]. The concentrations obtained by MALDI-TOFMS
are either lower or virtually identical to those obtained
previously. We note that the electrospray MS assay was
based on measurement of absolute analyte signal inten-
sity without inclusion of an internal standard, and
thereafter, the extracts were stored for ca. two years at
20 °C before the MALDI-TOFMS data were acquired.
It is reasonable to assume that some proteolysis oc-
curred in those samples with lower analyte concentra-
tions. Degradation likely arose during the repeat freeze-
thaw cycles.
Quantification of Low Molecular Weight Analytes
Catecholamines in human adrenal tissue. A spectrum
showing peaks for norepinephrine ([M  H] 
170.0817 Da), [2H3]-norepinephrine ([M  H]
 
173.1005 Da), epinephrine ([M  H]  184.0974 Da),
and [2H3]-epinephrine ([M  H]
  187.1161 Da) was
obtained in RDE mode (Figure 8). Instrument parame-
ters were optimized to provide the highest possible
resolution. Standard addition curves for both analytes,
Figure 6. Linear calibration curves for human insulin, using
porcine insulin as internal standard. Calibration curves were
acquired in (a) LDE mode (R2  0.999, slope  1.082) and (b) RDE
mode (R2  0.999, slope  0.981). The signal intensity ratio is the
ratio of the summed peak heights of the first 8 isotopes of human
insulin ([M  H]  5804.7 to 5811.7 Da) to that of the first eight
isotopes of porcine insulin ([M  H]  5774.7 to 5781.7 Da).
Table 2. Insulin concentrations in human pancreatic tissue. Insulin determinations for sections A, B and C of pancreas tissues 1 and 2
LDE modea RDE modea
Human insulin
(nmol/g tissue) CVb (%)
Human insulin
(nmol/g tissue) CVb (%)
Pancreas 1
A 20.9 1.6 19.7 6.1
B 18.7 1.4 18.2 7.1
C 16.8 2.9 16.1 6.8
Pancreas 2
A 12.6 3.3 12.1 6.4
B 15.2 2.3 13.6 11.2
C 12.9 3.0 10.7 6.6
aSamples were assayed in both LDE and RDE modes and values reported are the average of 10 determinations
bCV is the standard deviation expressed as the percentage of the mean (CV  /)
Figure 7. A comparison of LVV-hemorphin-7 concentrations in
human adrenal gland determined by MALDI-TOFMS and ESI-MS.
The values obtained by MALDI-TOFMS are the average of 10
separate determinations. Coefficients of variation (CV) for each
measurement were less than 10%.
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prepared in an extract of surgically resected adrenal
cortex, were assayed in ferulic acid matrix. The curves
were linear over the analyte added/internal standard
relative concentration ranges 0.02 to 2.0 for norepineph-
rine (R2  0.998) and 0.025 to 4.5 for epinephrine (R2 
0.999).
Table 3 shows the results for the analysis of three
sections of whole adrenal tissue and 3 pheochromocy-
toma samples. Initially, norepinephrine analyte/inter-
nal standard peak height ratios for the pheochromocy-
toma samples were higher than those obtained for the
highest standard in the calibration curve. The extracts
for these samples were reanalyzed using a higher
concentration (3 nmol/L extract) of the internal stan-
dard.
The catecholamine spectrum shown in Figure 8 illus-
trates the additional specificity available in RDE mode
for low molecular weight analytes. This is important
because in several samples, the signal for norepineph-
rine ([MH]  170.0817 Da) was not the most intense
at the nominal mass value of 170 Da. It was only
possible to accurately quantify norepinephrine in the
adrenal tissue extracts because its signal could be com-
pletely resolved from other peaks of the same nominal
mass. When spectra were internally calibrated, mass
assignments for both catecholamines were accurate to
better than 5 ppm. This limits possible elemental com-
positions to a unique formula, or just a few alternatives.
Homovanillic acid in human urine. Spectra showing sig-
nals for the protonated molecule of HVA (M 
182.0579 Da) and [2H5]-HVA (M
  187.0893 Da) were
obtained in RDE mode. Linear calibration curves were
constructed for the analyte/internal standard relative
concentration range 0 to 10 using either peak height
ratios or peak area ratios (peak height ratios: R2 0.999,
slope  0.972; peak area ratios: R2  0.999, slope 
1.055). (The spectra were of comparable resolution and
Figure 8. A representative MALDI-TOF mass spectrum for norepinephrine ([M  H]  170.0817
Da) and epinephrine ([M  H]  184.0974 Da) and their respective internal standards [2H3]-
norepinephrine ([M  H]  173.1005 Da), [2H3]-epinephrine ([M  H]
  187.1162 Da) in human
adrenal extracts. The spectrum was acquired in RDE mode.
Table 3. Catecholamine concentrations in human adrenal gland
Sample
Norepinephrinea Epinephrine
Mean value
(nmol/g tissue) CV (%)
Mean value
(nmol/g tissue) CV (%)
Adrenal gland A 233 16 279 6
Adrenal gland B 510 13 582 10
Adrenal gland C 499 17 690 19
Pheochromocytoma 1 3,989 7 184 16
Pheochromocytoma 2 6,708 8 2,854 8
Pheochromocytoma 3 59,940 5 5,735 4
aThe norepinephrine data for all pheochromocytoma samples were obtained using higher concentrations of the internal standards ([2H3]-
norepinephrine, i.e., 3 nmol/L extracts).
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mass accuracy to those obtained for epinephrine and
norepinephrine in tissue extracts.)
Homovanillic acid in urine was quantified using
DHB as the MALDI matrix, with coefficients of varia-
tion typically less than 20%. A representative mass
spectrum across the appropriate mass range is included
as Figure 9. The same urine samples were also indepen-
dently analyzed for homovanillic acid, and these results
were comparable to those obtained by MALDI-TOFMS.
Figure 10 compares the homovanillic acid values mea-
sured by a commercial clinical chemistry laboratory
(HPLC analysis) with those obtained by both peak
height (Figure 10a) and peak area ratios (Figure 10b).
Similar correlation coefficients were obtained for both
approaches (0.915 and 0.942 respectively).
Figure 11 shows the coefficients of variation (y-axis)
for the measured peak height ratios of homovanillic
acid/[2H5]-homovanillic (equimolar ratios in DHB)
when different number of laser shots is varied.
Conclusion
Our aim was to examine the utility of MALDI-TOFMS
for the quantification of endogeneous levels of a wide
range of biomolecules in complex biological matrices.
Rather than exhaustively explore limits of detection,
limits of quantification, linearity, precision and accu-
racy, we have simply selected a few example problems
to demonstrate that automated MALDI-TOFMS can
deliver good quantitative data for a wide range of
compounds in various complex biological matrices.
Linear calibration curves with R2  0.99 were routinely
constructed for analytes ranging in molecular weight
from 170 to 22 kDa. Analytes were quantified in crude
tissue extracts and urine with either similar compounds
Figure 9. A representative MALDI mass spectrum for homovanillic acid detected in human urine.
The internal standard [2H5]-homovanillic acid (100 pmol) was added prior to analysis. Samples were
analyzed in reflector mode using 2,5-dihydroxybenzoic acid as the MALDI matrix.
Figure 10. The values obtained for HVA in random urine sam-
ples (n  19) by MALDI-TOFMS calculated using (a) peak height
ratios and (b) peak area ratios were comparable with the concen-
tration measured using an independent established method. The
coefficient of variation for each urine sample, when analyzed by
MALDI-TOFMS, was less than 20%.
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of comparable molecular weight, structural analogs, or
isotopomers incorporated as internal standards.
A high degree of specificity was achieved using RDE
analysis for the catecholamine and HVA assays. The
mass resolution achieved in these assays allowed mea-
surement of specific analytes in the presence of contam-
inants of the same nominal mass and mass assignments
accurate to 5 ppm were possible. An assay dynamic
range of 2.5 orders of magnitude was readily achiev-
able. Some instrument dynamic range and signal satu-
ration problems were observed, but solutions or
workarounds for these were found and evaluated.
Precision
One of the most important objectives of method devel-
opment was to maximize assay precision whilst retain-
ing reasonable analysis times. In this study we deter-
mined that at least 75 laser shots from three target
positions are required to achieve reproducible ratios
and optimal precision (see Figure 11). In practice we
generally acquired the maximum number of shots (256)
permitted by the instrument software and incorporated
signals from at least 10 firing positions. Precision gen-
erally improved with absolute peak intensity, and co-
efficients of variation were below 20% for all assays in
this study.
During method development we examined peak
height ratio variation between different firing positions
within a sample spot, and between successive multi-
shot composite spectra acquired at the same firing
position (data not shown). For a given matrix and
sample combination, the variations were very similar,
regardless of whether the firing position changed be-
tween acquisitions. This is consistent with the three-
dimensional variation in the pattern of analyte—matrix
co-crystallization. We also noted that the variation was
greater for tissue extracts than for pure standards,
which supports the notion that variation is inherently
related to the cocrystallization process.
Accuracy
The accuracy of quantitative MALDI-TOFMS has been
demonstrated across an extended mass range. The
values determined here for rGH (2.40 and 2.49 mol/g
tissue) in rat pituitary tissues are within the published
normal range (2.3–3.2 mol/g tissue) [50]. The results
obtained for LVV-hemorphin-7 have been compared
with results obtained in an earlier electrospray MS
assay of the same extracts [49] and the spiked control
samples gave the expected elevation in LVV-hemorphin-7
relative to their respective unspiked counterparts, indicat-
ing that assay accuracy is acceptable.
The assay for epinephrine and norepinephrine in
adrenal tissue gave mean values of 517 213 and 414
157 nmol/g tissue for three tissue samples (published
mean values are 2700 and 600 nmol/g, respectively
[51]). Because some of the samples were collected from
cases of accidental death, epinephrine dumping to the
circulatory system may have occurred during the last
moments of life, lowering the adrenal epinephrine
content from its usual level.
The concentrations of HVA determined in urine by
MALDI-TOFMS are comparable to values obtained by
independent analysis. The correlation coefficient indi-
cates that accurate values can be obtained for low mass
analytes after minimal sample work-up, despite the
presence of contaminant and matrix ions.
Signal Saturation, Analysis Time, and Instrument
Dynamic Range
Avoiding signal saturation is a key concern with quan-
titative MALDI-TOFMS. If either the analyte or internal
standard signal saturates for one or more laser shots,
imprecision is introduced. The problem stems from two
sources: The limited dynamic range of the instrument’s
digitizer, and the unpredictable and large shot-to-shot
signal intensity variation seen with some samples. Re-
jection of composite intensity-averaged spectra, with
intensities near to the saturation limit, does not elimi-
nate the contributions of saturated data from individual
laser shots. Two satisfactory approaches to minimizing
or eliminating saturated data have been evaluated.
However, real solutions to the saturation issue lie in
improvement of digitizer dynamic range and minimi-
zation of shot-to-shot intensity variations for a given
laser power. Digitizer design is always a compromise
between sampling rate, dynamic range, and price. For-
tunately, the availability of units offering high sampling
rates and dynamic ranges is continually improving and
becoming more cost effective. The instrument dynamic
Figure 11. Shown are the coefficients of variation (y-axis) for the
measured peak height ratios of homovanillic acid/[2H5]-ho-
movanillic (equimolar ratios in DHB) when different number of
laser shots are acquired per spectrum (z-axis) and averaged across
a number of different target positions (x-axis).
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range issues discussed here are now being resolved by
hardware improvements.
Selection of Appropriate Internal Standards
For peptides and proteins, instrument response be-
comes less dependent on compound character as mo-
lecular weight increases (provided that pI values are
not drastically different). -Lactoglobulin and rGH are
very different but gave signals of similar intensity for
equimolar solutions. By way of contrast, epinephrine
and norepinephrine are relatively similar in structure,
but the instrument molar response ratio is 10:1. Internal
standard selection is therefore critical at low mass, and
here stable isotopomers are clearly the ideal choice. In
additional work (data not shown) we have compared
variation in the analyte/internal standard ratio using
2H versus 13C and 15N isotopomers. The variations
observed were not dependent on the label, even in a
complex sample matrix.
Low Molecular Weight Species and Accurate Mass
Determinations
Quantification of low molecular weight compounds by
MALDI-TOFMS is potentially powerful and this was
illustrated in the assays for the catecholamines, in
particular, for norepinephrine. In all of the low molec-
ular weight assays the spectra were acquired at the
fastest sampling rate available on the digitizer. We also
reduced the accelerating voltage from the usual 25 to 7
kV. This gave ion intensities similar to those seen at full
accelerating voltage but allowed a greater number of
digital samples over the peaks of interest. In this way
the peak shape was better described and a more precise
mass value was assigned.
Attributes of the Technique and Potential Areas of
Application
The determination of unique elemental composition for
unknown analytes, along with absolute quantitative
data may be valuable in both clinical and environmen-
tal analyses. These situations often require speed, min-
imal sample work-up, high specificity, and simplicity of
operation. Precision is sometimes less of a concern. For
example, in screening procedures where the analyte is
present in huge excess for abnormal cases, and speed is
very important, quantification by MALDI-TOFMS may
offer an ideal approach: Fast, specific, and sensitive.
Determinations involving high molecular weight
biomolecules—where electrospray mass spectrometry
would present complex spectra due to multiple charg-
ing effects—quantitative MALDI-TOFMS can prove
useful. The predominance of the singly charged species
in a complex mixture enables easier interpretation of
spectra, and the ability of MALDI-TOFMS to analyze
complex biological samples aids in eliminating the need
for chromatographic steps.
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